News
The latest price target for Sonnet BioTherapeutics (NASDAQ:SONN) was reported by Chardan Capital on March 28, 2025. The analyst firm set a price target for $20.00 expecting SONN to rise to within ...
Detailed price information for Sonnet Biot Inc (SONN-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback